{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:21:31Z","timestamp":1778656891573,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.vaccine.2008.05.012","type":"journal-article","created":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T17:24:14Z","timestamp":1211995454000},"page":"3885-3891","source":"Crossref","is-referenced-by-count":15,"title":["Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population"],"prefix":"10.1016","volume":"26","author":[{"given":"Amanda J.","family":"Leach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Balloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.vaccine.2008.05.012_bib1","first-page":"S27","article-title":"Merianos A: invasive pneumococcal disease in the Northern Territory of Australia 1994\u20131998","volume":"173","author":"Krause","year":"2000","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2008.05.012_bib2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00006454-199411000-00009","article-title":"Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants","volume":"13","author":"Leach","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.05.012_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2431-5-27","article-title":"Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey","volume":"5","author":"Morris","year":"2005","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.vaccine.2008.05.012_bib4","unstructured":"Australian Immunisation Handbook. 8th ed. 2003; 2007, p. 220\u201334."},{"key":"10.1016\/j.vaccine.2008.05.012_bib5","unstructured":"Balloch A, Mininni T, Nurkka A, Mackenzie G, Leach A, Kayhty H et al., Interlaboratory comparison of the specific IgG response to serotypes in Prevenar. In: 5th International Symposium on Pneumococci and Pneumococcal Diseases Alice Aprings, 2\u20136 April, 2006, PODT.31. 2007."},{"key":"10.1016\/j.vaccine.2008.05.012_bib6","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.012_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-6749(98)70089-2","article-title":"Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations","volume":"102","author":"Sorensen","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2008.05.012_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/00006454-200210000-00011","article-title":"Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine","volume":"21","author":"Obaro","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.05.012_bib9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/00006454-200211000-00006","article-title":"Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa","volume":"21","author":"Huebner","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.05.012_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1542\/peds.112.1.66","article-title":"Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection","volume":"112","author":"Nachman","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2008.05.012_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children, Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.05.012_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.inf.0000207483.60267.e7","article-title":"Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers","volume":"25","author":"Goldblatt","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.05.012_bib13","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.vaccine.2004.09.029","article-title":"Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants","volume":"23","author":"Esposito","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.012_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6815-6-10","article-title":"Measuring nasal bacterial load and its association with otitis media","volume":"6","author":"Smith-Vaughan","year":"2006","journal-title":"BMC Ear Nose Throat Disord"},{"key":"10.1016\/j.vaccine.2008.05.012_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/INF.0b013e31815bb6c5","article-title":"Random colony selection versus colony morphology for detection of multiple pneumococcal serotypes in nasopharyngeal swabs","volume":"27","author":"Hare","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.05.012_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.inf.0000151022.92222.be","article-title":"Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age","volume":"24","author":"Kayhty","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.05.012_bib17","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(95)91861-2","article-title":"Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine","volume":"346","author":"Shahid","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.05.012_bib18","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1016\/S0264-410X(03)00348-7","article-title":"Studies of maternal immunisation with pneumococcal polysaccharide vaccine in Papua New Guinea","volume":"21","author":"Lehmann","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.012_bib19","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/01.inf.0000143651.54880.09","article-title":"Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy","volume":"23","author":"Obaro","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.05.012_bib20","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.vaccine.2006.09.016","article-title":"Molecular characterisation of pneumococcal serotype 16F: Established predominant carriage and otitis media serotype in the 7vPCV era","volume":"25","author":"Marsh","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.012_bib21","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1016\/j.vaccine.2007.03.021","article-title":"Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies","volume":"25","author":"Quiambao","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.012_bib22","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1016\/j.vaccine.2007.06.021","article-title":"The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine","volume":"25","author":"Balmer","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.012_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1440-1754.2005.00588.x","article-title":"Current issues regarding the use of pneumococcal conjugate and polysaccharide vaccines in Australian children","volume":"41","author":"Mackenzie","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2008.05.012_bib24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/adc.56.5.354","article-title":"Immunisation with a polyvalent pneumococcal vaccine Effect of respiratory mortality in children living in the New Guinea highlands","volume":"56","author":"Riley","year":"1981","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2008.05.012_bib25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(86)90409-5","article-title":"Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children","volume":"2","author":"Riley","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.05.012_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/02724936.1991.11747510","article-title":"Effect of pneumococcal vaccine on morbidity from acute lower respiratory tract infections in Papua New Guinean children","volume":"11","author":"Lehmann","year":"1991","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.vaccine.2008.05.012_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(07)70210-4","article-title":"Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?","volume":"7","author":"O\u2019Brien","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2008.05.012_bib28","first-page":"1346","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.05.012_bib29","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.05.012_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-144-1-200601030-00004","article-title":"Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization","volume":"144","author":"Flannery","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2008.05.012_bib31","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.vaccine.2006.09.005","article-title":"Clear not simple: an approach to community consultation for a maternal pneumococcal vaccine trial among Indigenous women in the Northern Territory of Australia","volume":"25","author":"Dunbar","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T07:03:18Z","timestamp":1631343798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08005823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":31,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0264410X08005823"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.05.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}